Pediatric Drug Therapy 2012 - Hemangiomas: Evaluation, Referral and Breakthrough Pharmacologic Management
This online course is designed as a pharmacology update for nurse practitioners at the advanced practice level. Each module focuses on current recommendations and pharmacotherapeutic principles for pediatric health problems commonly seen in primary care.
Lectures were recorded in March 2012 at a conference in Seattle, Washington sponsored by the University of Washington School of Nursing. Teaching methods include lecture and downloadable handouts.
Publish Date: April 18, 2012. This course will be available for three years from this date.
This online course is designed as a pharmacology update for nurse practitioners, clinical nurse specialists, nurses and healthcare professionals in all settings. Each module focuses on current recommendations and pharmacotherapeutic principles for psychiatric and neurologic health problems commonly seen in primary care.
Objectives for Learning Outcomes
- Differentiate infantile hemangiomas (IM) from other vascular lesions.
- Describe indications for treatment of infantile hemangiomas versus watchful waiting.
- Discuss the use and monitoring of propranolol for infantile hemangiomas.
Ronna K. Smith, MN, ARNP
Nurse Practitioner, Otolaryngology Clinic, Seattle Children's Hospital, Seattle; Lecturer, Family and Child Nursing, University of Washington School of Nursing, Seattle
- 1.10 Contact hours
- 1.10 Pharmacology hours at the advanced practice level